Finally, inhibition of the mTOR (mammalian target of rapamycin) pathway, which was obtained by rapamycin administration through S6 kinase deletion, increases survival and reduces the incidence of age-related diseases, including immune dysfunction and insulin resistance [89]. Here, MTOR is linked to immune system disorder.